Product Overview
Selank is a synthetic tuftsin-derived heptapeptide supplied by Arche Research as a lyophilized material for lawful laboratory, analytical, and non-clinical research.
Research Context
Selank is a seven-amino acid synthetic peptide developed at the Institute of Molecular Genetics (Russian Academy of Sciences) as an analog of the endogenous tetrapeptide tuftsin (Thr-Lys-Pro-Arg). The Selank sequence extends tuftsin with a C-terminal Pro-Gly-Pro addition, resulting in a compound with extended metabolic stability relative to naturally occurring tuftsin. The peptide has been studied primarily for its effects on anxiety-related behaviors, gene expression in neuroinflammatory pathways, and immune-neuroendocrine interactions.
Research References
- Seredenina SB, et al. “Anxiolytic and nootropic effects of Selank.” Bulletin of Experimental Biology and Medicine. 2006;141(5):570–573. DOI: 10.1007/s10517-006-0232-6.
- Inozemtseva LS, et al. “Effect of Selank on the expression of genes involved in inflammatory processes.” Molecular Genetics, Microbiology and Virology. 2009;24(1):16–20. DOI: 10.3103/S0891416809010030.
- Kolomin TA, et al. “Selank affects the expression of genes involved in neuroinflammation and immune response.” Neurochemical Journal. 2020;14(1):45–51. DOI: 10.1134/S1819716120010086.
